Literature DB >> 22654963

Radiation treatment for patients with intermediate-risk prostate cancer.

David E Greene1, Jyoti S Mayadev, Richard K Valicenti.   

Abstract

Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.

Entities:  

Keywords:  androgen deprivation; brachytherapy; dose escalation; external beam; intermediate risk; outcomes; prostate cancer; radiation; review

Year:  2012        PMID： 22654963      PMCID： PMC3361750          DOI： 10.1177/1756287212442977

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN： 1756-2872


  68 in total

Review 1.  Minimizing prostate brachytherapy-related morbidity.

Authors:  Gregory S Merrick; Kent E Wallner; Wayne M Butler
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

2.  Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.

Authors:  James W Denham; Allison Steigler; David S Lamb; David Joseph; Sandra Turner; John Matthews; Chris Atkinson; John North; David Christie; Nigel A Spry; Keen-Hun Tai; Chris Wynne; Catherine D'Este
Journal:  Lancet Oncol       Date:  2011-05       Impact factor: 41.316

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer.

Authors:  J Laverdière; J L Gomez; L Cusan; E R Suburu; P Diamond; M Lemay; B Candas; A Fortin; F Labrie
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-01-15       Impact factor: 7.038

5.  Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer.

Authors:  Thomas P Boike; Yair Lotan; L Chinsoo Cho; Jeffrey Brindle; Paul DeRose; Xian-Jin Xie; Jingsheng Yan; Ryan Foster; David Pistenmaa; Alida Perkins; Susan Cooley; Robert Timmerman
Journal:  J Clin Oncol       Date:  2011-04-04       Impact factor: 44.544

6.  External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

Authors:  Michel Bolla; Geertjan Van Tienhoven; Padraig Warde; Jean Bernard Dubois; René-Olivier Mirimanoff; Guy Storme; Jacques Bernier; Abraham Kuten; Cora Sternberg; Ignace Billiet; José Lopez Torecilla; Raphael Pfeffer; Carmel Lino Cutajar; Theodore Van der Kwast; Laurence Collette
Journal:  Lancet Oncol       Date:  2010-10-07       Impact factor: 41.316

7.  Definition of the prostate in CT and MRI: a multi-observer study.

Authors:  C Rasch; I Barillot; P Remeijer; A Touw; M van Herk; J V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

Review 8.  Complications following permanent prostate brachytherapy.

Authors:  N N Stone; R G Stock
Journal:  Eur Urol       Date:  2002-04       Impact factor: 20.096

9.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; K Blank; G A Broderick; J E Tomaszewski; A A Renshaw; I Kaplan; C J Beard; A Wein
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272

10.  Impact of the percentage of positive prostate cores on prostate cancer-specific mortality for patients with low or favorable intermediate-risk disease.

Authors:  Anthony V D'Amico; Andrew A Renshaw; Kerri Cote; Mark Hurwitz; Clair Beard; Marian Loffredo; Ming-Hui Chen
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544
View more
  1 in total

Review 1.  Intravesical Therapies for Radiation Cystitis.

Authors:  Konstantinos Giannitsas; Anastasios Athanasopoulos
Journal:  Curr Urol       Date:  2015-11-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.